Karin Eastham

CIK: 0001231845

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)13 (59.1%)

Position reduction

Option Exercises (M)4 (18.2%)

Derivative conversions

Awards (A)5 (22.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

VCYT

VERACYTE, INC.

Director

PSNL

Personalis, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (22 total)

VCYT
VERACYTE, INC.
Oct 27, 2026
Sale(S)
Direct
14.9K shares at avg. $50.00$743K
VCYT
VERACYTE, INC.
Oct 27, 2026
Exercise(M)
Direct
10K shares at avg. $27.01$270K
VCYT
VERACYTE, INC.
Jun 18, 2026
Sale(S)
Direct
3.2K shares at avg. $52.78$169K
VCYT
VERACYTE, INC.
Jun 18, 2026
Sale(S)
Direct
529 shares at avg. $53.55$28K
VCYT
VERACYTE, INC.
Jun 11, 2026
Award(A)
Direct
5.3K shares-
PSNL
Personalis, Inc.
May 12, 2026
Award(A)
Direct
6.3K shares-
PSNL
Personalis, Inc.
May 12, 2026
Award(A)
Stock Option (right to buy)
Direct
37.5K shares-
VCYT
VERACYTE, INC.
Dec 5, 2025
Exercise(M)
Direct
10K shares at avg. $7.94$79K
VCYT
VERACYTE, INC.
Dec 5, 2025
Sale(S)
Direct
800 shares at avg. $46.59$37K
VCYT
VERACYTE, INC.
Dec 5, 2025
Sale(S)
Direct
12.8K shares at avg. $45.84$587K
VCYT
VERACYTE, INC.
Dec 5, 2025
Sale(S)
Direct
6.4K shares at avg. $44.52$285K
VCYT
VERACYTE, INC.
Dec 5, 2025
Exercise(M)
Direct
10K shares at avg. $7.60$76K
VCYT
VERACYTE, INC.
Nov 5, 2025
Sale(S)
Direct
9.7K shares at avg. $40.02$387K
VCYT
VERACYTE, INC.
Jun 18, 2025
Award(A)
Direct
9.3K shares-
VCYT
VERACYTE, INC.
Jun 13, 2025
Sale(S)
Direct
4.6K shares at avg. $26.66$122K
PSNL
Personalis, Inc.
May 16, 2025
Award(A)
Stock Option (right to buy)
Direct
50K shares-
VCYT
VERACYTE, INC.
Jan 2, 2025
Sale(S)
Direct
5.3K shares at avg. $40.12$213K
VCYT
VERACYTE, INC.
Jan 2, 2025
Exercise(M)
Direct
10K shares at avg. $5.28$53K
VCYT
VERACYTE, INC.
Jan 2, 2025
Sale(S)
Direct
4.7K shares at avg. $40.50$190K
VCYT
VERACYTE, INC.
Nov 19, 2024
Sale(S)
Direct
10.1K shares at avg. $38.76$392K
VCYT
VERACYTE, INC.
Nov 19, 2024
Sale(S)
Direct
1.6K shares at avg. $36.77$59K
VCYT
VERACYTE, INC.
Nov 19, 2024
Sale(S)
Direct
3K shares at avg. $37.77$114K

		Type	Shares	Price		Ownership
Oct 27, 2026	VCYT VERACYTE, INC.	Sale(S)	14,850	$50.00	$742,573	Direct
Oct 27, 2026	VCYT VERACYTE, INC.	Exercise(M)	10,000	$27.01	$270,100	Direct
Jun 18, 2026	VCYT VERACYTE, INC.	Sale(S)	3,200	$52.78	$168,906	Direct
Jun 18, 2026	VCYT VERACYTE, INC.	Sale(S)	529	$53.55	$28,328	Direct
Jun 11, 2026	VCYT VERACYTE, INC.	Award(A)	5,272	-	$0	Direct
May 12, 2026	PSNL Personalis, Inc.	Award(A)	6,250	-	$0	Direct
May 12, 2026	PSNL Personalis, Inc.	Award(A) Stock Option (right to buy)	37,500	-	-	Direct
Dec 5, 2025	VCYT VERACYTE, INC.	Exercise(M)	10,000	$7.94	$79,400	Direct
Dec 5, 2025	VCYT VERACYTE, INC.	Sale(S)	800	$46.59	$37,272	Direct
Dec 5, 2025	VCYT VERACYTE, INC.	Sale(S)	12,808	$45.84	$587,080	Direct
Dec 5, 2025	VCYT VERACYTE, INC.	Sale(S)	6,392	$44.52	$284,571	Direct
Dec 5, 2025	VCYT VERACYTE, INC.	Exercise(M)	10,000	$7.60	$76,000	Direct
Nov 5, 2025	VCYT VERACYTE, INC.	Sale(S)	9,674	$40.02	$387,191	Direct
Jun 18, 2025	VCYT VERACYTE, INC.	Award(A)	9,321	-	-	Direct
Jun 13, 2025	VCYT VERACYTE, INC.	Sale(S)	4,590	$26.66	$122,388	Direct
May 16, 2025	PSNL Personalis, Inc.	Award(A) Stock Option (right to buy)	50,000	-	-	Direct
Jan 2, 2025	VCYT VERACYTE, INC.	Sale(S)	5,309	$40.12	$213,010	Direct
Jan 2, 2025	VCYT VERACYTE, INC.	Exercise(M)	10,000	$5.28	$52,800	Direct
Jan 2, 2025	VCYT VERACYTE, INC.	Sale(S)	4,691	$40.50	$189,996	Direct
Nov 19, 2024	VCYT VERACYTE, INC.	Sale(S)	10,125	$38.76	$392,405	Direct
Nov 19, 2024	VCYT VERACYTE, INC.	Sale(S)	1,600	$36.77	$58,826	Direct
Nov 19, 2024	VCYT VERACYTE, INC.	Sale(S)	3,006	$37.77	$113,538	Direct

1-22 of 22 transactions

About EASTHAM KARIN

EASTHAM KARIN (SEC CIK 0001231845) files insider reports with the SEC as Director of VERACYTE, INC. (VCYT) and Director of Personalis, Inc. (PSNL).

Signal8 holds 12 ownership filings by EASTHAM KARIN, all Form 4s, filed between Nov 21, 2024 and Oct 28, 2026. Those filings report 22 transactions, from Nov 19, 2024 to Oct 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on EASTHAM KARIN's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by EASTHAM KARIN

Oct 27, 2026: Open-market sale of VCYT shares (Form 4, code S).
Oct 27, 2026: Option exercise of VCYT shares (Form 4, code M).
Jun 18, 2026: Open-market sales of VCYT shares (2 lines, Form 4, code S).
Jun 11, 2026: Grant or award of VCYT shares (Form 4, code A).
May 12, 2026: Grants or awards of PSNL shares (2 lines, Form 4, code A).

Other insiders filing for VERACYTE, INC. (VCYT)

Wygant Jonathan, VP, Chief Accounting Officer
Holstein Jens, Director
Bhanji Muna, Director
Leite John, Global Chief Commercial Off
Febbo Phillip G., Chief Scientific & Med Officer
Chambers Rebecca, Chief Financial Officer

How to read Form 4 transaction codes